🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Examine the ability of thymopentin (Timunox) to: Reduce the amount and/or ...
Status
Completed
Location
Immunobiology Research Institute
Start Date
TBD
Trial ID
NCT00002051
Treatments Being Tested
Examine the ability of Timunox (thymopentin) to reduce the amount and/or fr...
Status
Completed
Location
Immunobiology Research Institute
Start Date
TBD
Trial ID
NCT00002289
Treatments Being Tested
To evaluate the mechanism whereby thymopentin appears to retard the progres...
Status
Completed
Location
Dr Marcus Conant
Start Date
TBD
Trial ID
NCT00002332
Treatments Being Tested
To confirm results from a previous study in which the combination of thymop...
Status
Completed
Location
Fisher Med Group
Start Date
TBD
Trial ID
NCT00002109
Treatments Being Tested
The purpose of this study is to evaluate the clinical efficacy of thymopent...
Status
Unknown
Location
Liver Cancer Institute and Zhongshan Hospital, Fudan University
Start Date
2007-02
Trial ID
NCT00460681
Treatments Being Tested
Examine the ability of thymopentin (Timunox) to: Reduce the amount and/or ...
Status
Completed
Location
Immunobiology Research Institute
Start Date
TBD
Trial ID
NCT00002066
Treatments Being Tested
This is an open-label, single-arm, Phase II investigator-initiated trial of...
Status
Not Yet Recruiting
Location
Second Affiliated Hospital of Soochow University
Start Date
2023-10-25
Trial ID
NCT06112041
Treatments Being Tested
Examine the ability of Timunox (thymopentin) to reduce the amount and/or fr...
Status
Completed
Location
Immunobiology Research Institute
Start Date
TBD
Trial ID
NCT00002049
Treatments Being Tested
Examine the ability of Timunox (thymopentin) to reduce the amount and/or fr...
Status
Completed
Location
Immunobiology Research Institute
Start Date
TBD
Trial ID
NCT00002050
Treatments Being Tested
A Phase I, Randomized, Double-Blind, Placebo-Controlled, First-in-human, Si...
Status
Completed
Location
Hassman Research Inc
Start Date
2024-02-20
Trial ID
NCT05978908